Birgitta Leuthner

2PUBLICATIONS
28CO-AUTHORS
Molecular targetsProteins and peptides
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

Sort by Publication Date:
|Feb 28, 2025
M4205 (IDRX-42) Is a Highly Selective and Potent Inhibitor of Relevant Oncogenic Driver and Resistance Variants of KIT in Cancer.

Christina Esdar, Nina Linde, Andreas Blum

|Nov 08, 2023
Novel Methionine Aminopeptidase 2 Inhibitor M8891 Synergizes with VEGF Receptor Inhibitors to Inhibit Tumor Growth of Renal Cell Carcinoma Models.

Manja Friese-Hamim, Maria J Ortiz Ruiz, Olga Bogatyrova

Pageof 1

Frequent Collaborators

2 joint publications

Andree Blaukat

1 joint publications

Manja Friese-Hamim

1 joint publications

Maria J Ortiz Ruiz

1 joint publications

Olga Bogatyrova

1 joint publications

Marina Keil

1 joint publications

Felix Rohdich

1 joint publications

Beatrix Blume

1 joint publications

Frank Czauderna

1 joint publications

Diane Hahn

1 joint publications

Julia Jabs

Frequent Collaborators

2 joint publications

Andree Blaukat

1 joint publications

Manja Friese-Hamim

1 joint publications

Maria J Ortiz Ruiz

1 joint publications

Olga Bogatyrova

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on : Sep 30, 2016

13.6K
Modeling Spontaneous Metastatic Renal Cell Carcinoma (mRCC) in Mice Following Nephrectomy
11:27

Modeling Spontaneous Metastatic Renal Cell Carcinoma (mRCC) in Mice Following Nephrectomy

Published on : Apr 29, 2014

16.7K
See more related videos

Top Related Videos

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on : Sep 30, 2016

13.6K
Modeling Spontaneous Metastatic Renal Cell Carcinoma (mRCC) in Mice Following Nephrectomy
11:27

Modeling Spontaneous Metastatic Renal Cell Carcinoma (mRCC) in Mice Following Nephrectomy

Published on : Apr 29, 2014

16.7K
See more related videos